Ottmann, Oliver G.  ORCID: https://orcid.org/0000-0001-9559-1330, Müller-Tidow, Carsten, Krämer, Alwin, Schlenk, Richard F., Lübbert, Michael, Bug, Gesine, Krug, Utz, Bochtler, Tilmann, Voss, Florian, Taube, Tillmann, Liu, Dan, Garin-Chesa, Pilar and Döhner, Hartmut
2019.
Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia.
British Journal of Haematology
184
(6)
, pp. 1018-1021.
10.1111/bjh.15204
|
Preview |
PDF
- Accepted Post-Print Version
Download (484kB) | Preview |
Official URL: http://dx.doi.org/10.1111/bjh.15204
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Publisher: | Wiley |
| ISSN: | 0007-1048 |
| Date of First Compliant Deposit: | 3 June 2019 |
| Date of Acceptance: | 3 June 2018 |
| Last Modified: | 27 Nov 2024 07:15 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/123126 |
Citation Data
Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Altmetric
Altmetric